MorphoSys AG (MOR)
17.89
+0.02
(+0.11%)
USD |
NASDAQ |
May 03, 16:00
17.90
+0.01
(+0.06%)
After-Hours: 20:00
MorphoSys Free Cash Flow (Quarterly)
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -138.64M |
| March 31, 2023 | -76.97M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | -95.86M |
| March 31, 2022 | -162.69M |
| December 31, 2021 | -198.47M |
| September 30, 2021 | -228.56M |
| June 30, 2021 | -121.68M |
| March 31, 2021 | -51.87M |
| December 31, 2020 | -95.38M |
| September 30, 2020 | -71.25M |
| June 30, 2020 | -81.14M |
| March 31, 2020 | 231.70M |
| December 31, 2019 | -47.38M |
| September 30, 2019 | 3.743M |
| June 30, 2019 | -24.43M |
| March 31, 2019 | -26.80M |
| December 31, 2018 | -30.03M |
| September 30, 2018 | 35.51M |
| June 30, 2018 | -14.86M |
| March 31, 2018 | -32.24M |
| December 31, 2017 | -4.460M |
| September 30, 2017 | -21.02M |
| June 30, 2017 | -22.76M |
| Date | Value |
|---|---|
| March 31, 2017 | -10.20M |
| December 31, 2016 | -22.23M |
| September 30, 2016 | -13.80M |
| June 30, 2016 | -8.674M |
| March 31, 2016 | -10.11M |
| December 31, 2015 | -22.48M |
| September 30, 2015 | -8.285M |
| June 30, 2015 | -2.183M |
| March 31, 2015 | -2.870M |
| December 31, 2014 | -16.96M |
| September 30, 2014 | -12.88M |
| June 30, 2014 | -3.832M |
| March 31, 2014 | -12.47M |
| December 31, 2013 | -16.68M |
| September 30, 2013 | 132.61M |
| June 30, 2013 | -11.65M |
| March 31, 2013 | 6.722M |
| December 31, 2012 | -1.862M |
| September 30, 2012 | 4.009M |
| June 30, 2012 | -4.791M |
| March 31, 2012 | 1.975M |
| December 31, 2011 | -14.60M |
| September 30, 2011 | 3.226M |
| June 30, 2011 | 29.60M |
| March 31, 2011 | 14.49M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-228.56M
Minimum
Sep 2021
231.70M
Maximum
Mar 2020
-77.26M
Average
-81.14M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Incyte Corp | 209.26M |
| Novartis AG | 1.109B |
| Immatics NV | 76.06M |
| Affimed NV | -27.55M |
| InflaRx NV | -11.65M |